Tenon Medical (TNON) director gains 10,732 shares through RSU conversion
Rhea-AI Filing Summary
Tenon Medical, Inc. director Robert K. Weigle converted 10,732 Restricted Stock Units, granted on October 13, 2025, into 10,732 shares of common stock on July 31, 2026 at $0.00 per share. After this RSU conversion, he directly held 18,284 shares of Tenon Medical common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 10,732 shares
Net Buy
2 txns
Insider
WEIGLE ROBERT K
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units F1, F2 | 10,732 | $0.00 | $0.00 |
| Exercise | Common Stock F1 | 10,732 | $0.00 | $0.00 |
Holdings After Transaction:
Restricted Stock Units — 0 shares (Direct);
Common Stock — 18,284 shares (Direct)
Footnotes (2)
- F1. Represents conversion of 10,732 restricted stock units granted to the reporting person on October 13, 2025 into 10,732 shares of common stock of the Issuer on July 31, 2026.
- F2. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.
Key Figures
RSUs converted: 10,732 units
Common shares acquired: 10,732 shares
Shares held after transaction: 18,284 shares
+3 more
6 metrics
RSUs converted
10,732 units
Restricted Stock Units converted into common stock on July 31, 2026
Common shares acquired
10,732 shares
Shares of common stock received from RSU conversion on July 31, 2026
Shares held after transaction
18,284 shares
Direct common stock holdings of Robert K. Weigle following the RSU conversion
Per-share conversion price
$0.00 per share
Reported transaction price for the RSU-to-common stock conversion
RSU grant date
October 13, 2025
Date the 10,732 Restricted Stock Units were originally granted
Conversion date
July 31, 2026
Date RSUs converted into common stock
Key Terms
Restricted Stock Units, derivative security, Rule 10b5-1, acquired/disposed code
4 terms
Restricted Stock Units financial
"Represents conversion of 10,732 restricted stock units granted to the reporting person"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
derivative security financial
"transaction_code_description": "Exercise or conversion of derivative security""
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
Rule 10b5-1 regulatory
"aff_10b5_one is the filing's document-level Rule 10b5-1 checkbox"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
acquired/disposed code financial
"transaction_direction_source": "acquired_disposed_code""
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did Tenon Medical (TNON) report for Robert K. Weigle?
Tenon Medical reported that director Robert K. Weigle converted 10,732 Restricted Stock Units into 10,732 shares of common stock on July 31, 2026. This was an option/RSU exercise, not an open-market purchase or sale.
When were the Tenon Medical (TNON) Restricted Stock Units granted and converted?
The Form 4 states that 10,732 Restricted Stock Units were granted on October 13, 2025 and converted into 10,732 common shares on July 31, 2026. This reflects the vesting and settlement schedule of that equity award.
Was the Tenon Medical (TNON) insider transaction under a Rule 10b5-1 trading plan?
The filing’s Rule 10b5-1 checkbox is not marked as affirmatively under a plan. The reported activity is an RSU conversion rather than a discretionary market trade, and no separate trading plan is cited in the footnotes.